Pharmaceutical Barium sulfate
The Geology of Trust: Emerita, David Patterson and Spain’s Mining Gamble
I first started looking more closely at Emerita Resources Corp. (TSXV: EMO | OTCQX: EMOTF | FSE: LLJA)…
- May 2026
- April 2026
- March 2026
- February 2026
- January 2026
- December 2025
- November 2025
- October 2025
- September 2025
- August 2025
- July 2025
- June 2025
- May 2025
- April 2025
- March 2025
- February 2025
- January 2025
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
-
Voyageur Advances Mine-to-Bottle Strategy for Critical Mineral Barium and Iodine Contrast Products
June 26, 2025 — Prices for pharmaceutical-grade barium sulfate “are up over 40-50% in just a few months,”…
No CommentsInvestorNews
-
InvestorTalk Alert: Brent Willis from Voyageur Pharmaceuticals Ltd. to host on Wednesday, June 25, 2025 at 9 AM EST
InvestorNews.com is pleased to announce an upcoming InvestorTalk scheduled for tomorrow, Wednesday, June 25th, at 9 AM EST, featuring Brent Willis, President, CEO,…
No CommentsInvestorNews
-
InvestorTalk Alert: Brent Willis from Voyageur Pharmaceuticals Ltd. to host on Thursday, February 6, 2025
Investor.News is pleased to announce an upcoming InvestorTalk scheduled for tomorrow, Thursday, February 6th, at 9 AM EST,…
No CommentsInvestorNews
-
Voyageur Pharmaceuticals’ Brent Willis on the Indispensable Role of Barium
January 27, 2025 — In an enlightening interview on Investor.News, Brent Willis, President, CEO, and Director of Voyageur Pharmaceuticals…
No CommentsInvestorNews
-
Brent Willis on Voyageur Pharmaceuticals’ Shift to Innovative Barium Contrast Formulations and an FDA Update
September 17, 2024 — In a recent interview with InvestorNews host Tracy Hughes, Brent Willis, President, CEO, and Director…
No CommentsInvestorNews
-
Brent Willis on Voyageur’s ambition to revolutionize radiology by vertically integrating the barium and iodine contrast market
June 3, 2024 — InvestorNews host Pat Bolland interviews Brent Willis, President, CEO, and Director of Voyageur Pharmaceuticals Ltd. (TSXV:…
No CommentsInvestorNews
-
Voyageur Pharmaceutical’s Brent Willis on Revolutionizing the Medical Imaging Industry, plus SmoothX
In a revealing interview on Investor.Coffee, host Tracy Weslosky engages in an enlightening conversation with Brent Willis, President,…
No CommentsInvestorNews
-
Brent Willis of Voyageur Pharmaceuticals discusses the high IRR and NPV in its recent PEA
In a recent InvestorIntel interview, Tracy Weslosky spoke with Brent Willis, President and CEO of Voyageur Pharmaceuticals Ltd. (TSXV:…
3 CommentsInvestorNews
InvestorNews Member News
-
Appia Announces Signing of Share Exchange Agreement with Ultra Rare Earth Inc.
-
Quantum eMotion Files Q1 Interim Financial Statements and MD&A; Confirms Annual Filings on File with SEC and Canadian Securities Regulators
-
West High Yield (W.H.Y.) Resources Ltd. Announces Private Placement Offering
-
Appia Rare Earths & Uranium Corp. Qualifies for Third Consecutive Saskatchewan TMEI Grant of $70,910.87
-
Silver Bullet Mines Corp. Announces Adoption of Semi-Annual Reporting and Reliance on Quarterly Reporting Exemption Under Coordinated Blanket Order 51-933
